Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977–2001

References

• Sundhedsstyrelsen. Cancer incidence in Denmark 2001. Danish National Board of Health 2006.
   Google Scholar
• Storm H, Engholm G. Rerlativ overlevelse for danske kræftpatienter 1981 til 1997 og fulgt til år 2001 – en status. Ugeskr Lager 2002; 164: 2855–64
   PubMedGoogle Scholar
• Early breast cancer trialist's collaborative group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005;365:1687–717.
   PubMed Web of Science ®Google Scholar
• Early breast cancer trialist's collaborative group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15- year survival: An overview of the randomised trials. Lancet 2005;366:2087–106.
   PubMed Web of Science ®Google Scholar
• Mellemkjær L, Friis S, Olsen JH, Scélo G, Hemminki K, Tracey E, et al. Risk of second cancer among women with breast cancer. Int J Cancer 2006; 118: 2285–92
   PubMed Web of Science ®Google Scholar
• Brown LM, Chen BE, Pfeiffer RM, Schairer C, Hall P, Storm H, et al. Risk of second non-hematological cancer among 376,825 breast cancer survivors. Breast Cancer Res Treat 2007; 106: 439–51
   PubMed Web of Science ®Google Scholar
• Curtis RE, Ron E, Hankey BF, Hoover RN. Chapter 7. New malignancies following breast cancer. In: Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, et al New malignancies among cancer survivors: SEER cancer registries, 1973–2000. National Cancer Institute, NIH Publ. No. 05-5302. Bethesda, MD, 2006.
   Google Scholar
• Danish Breast Cancer Cooperative Group home page: http://www.dbcg.dk ( in Danish. Last visited July 9, 2007)
   Google Scholar
• Jensen AR, Overgaard J, Storm HH. Validity of breast cancer in the Danish Cancer Registry. A study based on clinical records from one county in Denmark. Eur J Cancer Prev 2002; 11: 359–64
   PubMed Web of Science ®Google Scholar
• Engholm G, Storm HH, Ferlay J, Christensen N, Bray F, Ólafsdóttir E, et al. NORDCAN: Cancer incidence and mortality in the Nordic Countries, Version 3.0. Association of Nordic Cancer Registries. Danish Cancer Society. ( http://www.ancr.nu) (2007).
   Google Scholar
• Boice JD, Jr. Ionizing radiation. Cancer epidemiology and prevention, D Schottenfeld, JF Fraumeni. Oxford University Press, New York 2006; 259–293
   Google Scholar
• Soerjomataram I, Louwman WJ, de Vries E, Lemmens VE, Klokman WJ, Coebergh JW. Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972–2001. Breast Cancer Res Treat 2005; 93: 91–5
   PubMed Web of Science ®Google Scholar
• Rubino C, Shamsaldin A, Le MG, Labbe M, Guinebretiere JM, Chavaudra J, et al. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment. Breast Cancer Res Treat 2005; 89: 277–88
   PubMed Web of Science ®Google Scholar
• Roychoudhuri R, Evans H, Robinson D, Moller H. Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer 2004; 91: 868–72
   PubMed Web of Science ®Google Scholar
• Deutsch M, Land SR, Begovic M, Wieand HS, Wolmark N, Fisher B. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. Cancer 2003; 98: 1362–8
   PubMed Web of Science ®Google Scholar
• Matheson JB, Burmeister BH, Smithers BM, Gotley D, Harvey JA, Doyle L. Second primary oesophageal cancer following radiation for breast cancer. Radiother Oncol 2002; 65: 159–63
   PubMed Web of Science ®Google Scholar
• Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Grimaud E, Labbe M, et al. Radiation dose, chemotherapy and risk of lung cancer after breast cancer treatment. Breast Cancer Res Treat 2002; 75: 15–24
   PubMed Web of Science ®Google Scholar
• Huang J, Mackillop WJ. Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer 2001; 92: 172–80
   PubMed Web of Science ®Google Scholar
• Ahsan H, Neugut AI. Radiation therapy for breast cancer and increased risk for esophageal carcinoma. Ann Intern Med 1998; 128: 114–7
   PubMed Web of Science ®Google Scholar
• Karlsson P, Holmberg E, Johansson KA, Kindblom LG, Carstensen J, Wallgren A. Soft tissue sarcoma after treatment for breast cancer. Radiother Oncol 1996; 38: 25–31
   PubMed Web of Science ®Google Scholar
• Doherty MA, Rodger A, Langlands AO, Kerr GR. Multiple primary tumours in patients treated with radiotherapy for breast cancer. Radiother Oncol 1993; 26: 125–31
   PubMed Web of Science ®Google Scholar
• Neugut AI, Robinson E, Lee WC, Murray T, Karwoski K, Kutcher GJ. Lung cancer after radiation therapy for breast cancer. Cancer 1993; 71: 3054–7
   PubMed Web of Science ®Google Scholar
• Darby S, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005; 6: 557–65
   PubMed Web of Science ®Google Scholar
• Cuzick J, Powles T, Veronesi U, Forbes J, Edwards R, Ashley S, et al. Overview of the main outcomes in breast-cancer prevention trials. Lancet 2003; 361: 296–300
   PubMed Web of Science ®Google Scholar
• Welsch PL, King MC. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 2001; 10: 705–13
   PubMed Web of Science ®Google Scholar